Prevalence of blood-borne viruses among intravenous drug users and alcoholics in Hiroshima, Japan

被引:6
|
作者
Ichimura, H [1 ]
Kurimura, O [1 ]
Tamura, I [1 ]
Tsukue, I [1 ]
Tsuchie, H [1 ]
Kurimura, T [1 ]
机构
[1] KURIHAMA NATL HOSP,INST CLIN RES,HIROSHIMA,JAPAN
关键词
HIV; HTLV; V3; sequence; HCV; HBV; HDV;
D O I
10.1177/095646249500600613
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the prevalence of human immunodeficiency viruses-1 and 2 (HIV-1 and HIV-2), human T-lymphotropic virus type I and II, hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus among intravenous drug users (IVDU) in Hiroshima, Japan, where little is known about their present levels. From June to December 1993, serum samples were collected from 47 IVDU and 98 alcoholics in Hiroshima, Japan, and examined for markers of virus infection. The prevalence of antibody to HCV (anti-HCV) and/or HCV-RNA was significantly higher in IVDU than alcoholics (74.5% vs 20.4%, 44.7% vs 10.2% respectively, P<0.001). In contrast, the prevalence of antibody to hepatitis B surface antigen and/or core antigen (anti-HBs and/or anti-HBc) showed no significant difference between the 2 groups (57.4% vs 66.3%). HIV-1 infection was found in one (2.1%) IVDU and genome analysis indicated that it was subtype B according to Myers' classification. Thus, an extremely low level of HIV infection and a high level of HCV infection was found in IVDU. Careful follow-up of this group is thought to be needed to minimize an outbreak of HIV-1 infection in Japan.
引用
收藏
页码:441 / 443
页数:3
相关论文
共 50 条
  • [1] Symbiotic Goals and the Prevention of Blood-Borne Viruses Among Injection Drug Users
    Friedman, Samuel R.
    Sandoval, Milagros
    Mateu-Gelabert, Pedro
    Meylakhs, Peter
    Jarlais, Don C. Des
    SUBSTANCE USE & MISUSE, 2011, 46 (2-3) : 307 - 315
  • [2] Incarceration is a major risk factor for blood-borne infection among intravenous drug users
    Mir-Nasseri, Mohammad Mehdi
    Mohammadkhani, Ashraf
    Tavakkoli, Hamid
    Ansari, Esmaeil
    Poustchi, Hossein
    HEPATITIS MONTHLY, 2011, 11 (01) : 19 - 22
  • [3] The prevalence and risk behaviours associated with the transmission of blood-borne viruses among ethnic-Vietnamese injecting drug users
    Hellard, Margaret. E.
    Nguyen, Oanh K.
    Guy, Rebecca J.
    Jardine, Darren
    Mijch, Anne
    Higgs, Peter G.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2006, 30 (06) : 519 - 525
  • [4] HIV REVISITED - PREVENTING THE SPREAD OF BLOOD-BORNE VIRUSES AMONG INJECTING DRUG-USERS
    WODAK, A
    CROFTS, N
    AUSTRALIAN JOURNAL OF PUBLIC HEALTH, 1994, 18 (03): : 239 - 240
  • [5] Changes in Blood-borne Infection Risk Among Injection Drug Users
    Mehta, Shruti H.
    Astemborski, Jacqueline
    Kirk, Gregory D.
    Strathdee, Steffanie A.
    Nelson, Kenrad E.
    Vlahov, David
    Thomas, David L.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (05): : 587 - 594
  • [6] PREVALENCE OF BLOOD-BORNE VIRUSES AMONG IRANIAN DENTISTS: RESULTS OF A NATIONAL SURVEY
    Akhoundi, Mohammad Sadegh Ahmad
    Momeni, Nafiseh
    Norouzi, Mehdi
    Ghalichi, Leila
    Shamshiri, Ahmad Reza
    Alavian, Seyed Moayed
    Poortahmasebi, Vahdat
    Jazayeri, Seyed Mohammad
    INTERNATIONAL JOURNAL OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH, 2015, 28 (03) : 593 - 602
  • [7] Epidemiology of HIV and other blood-borne pathogens among intravenous drug users starting detoxification programs in Barcelona
    Muga, R
    CLINICAL INFECTIOUS DISEASES, 2003, 37 : S480 - S480
  • [8] Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users
    Li, Jan-Rong
    Gong, Rui-Yu
    Tian, Kun-Lun
    Wang, Ing
    Wang, Yi-Xin
    Huang, Han-U
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (16) : 2357 - 2362
  • [10] Comparing population estimates for drug users, the prevalence of blood-borne viruses and the provision of services in one London borough: Evidence of a gap in provision?
    Cathcart, Simon
    Patton, Robert
    Hickman, Matthew
    Hendry, Chiara
    Ashworth, Mark
    DRUGS-EDUCATION PREVENTION AND POLICY, 2007, 14 (03) : 205 - 215